Screener
Tandem Diabetes Care TNDM EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Tandem Diabetes Care’s reported figures.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
FAQ
- What is Tandem Diabetes Care's EBITDA?
- Tandem Diabetes Care (TNDM) reported EBITDA of -$9.32M in Q2 2026.
- How has Tandem Diabetes Care's EBITDA changed year-over-year?
- Tandem Diabetes Care's EBITDA increased by 80.4% year-over-year, from -$47.44M to -$9.32M.
- What is the long-term trend for Tandem Diabetes Care's EBITDA?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's EBITDA has grown at a 46.8% compound annual growth rate (CAGR), from $36.5M to -$169.59M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Tandem Diabetes Care's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude